The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Polypharmacy and premature aromatase inhibitor (AI) discontinuation in older women with breast cancer.
 
Elizabeth Joyce
No Relationships to Disclose
 
Kelley M. Kidwell
Honoraria - Mallinckrodt
 
Vered Stearns
Consulting or Advisory Role - Novartis
Research Funding - Abbvie (Inst); Biocept (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Other Relationship - AstraZeneca
 
Daniel F. Hayes
Stock and Other Ownership Interests - InBiomotion
Honoraria - Tempus
Consulting or Advisory Role - BioVica; Cellworks; Cepheid; Epic Sciences; Freenome; Guardant Health; L-Nutra; Macrogenics; Oncocyte; Predictus Biosciences; Tempus; Turnstone Bio; xilis
Research Funding - AstraZeneca (Inst); Cepheid/Danaher (Inst); Menarini Silicon Biosystems (Inst); Merrimack (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Circulating Tumor Cell Capturing Techniques and Devices. Patent No.: US 8,951,484 B2. Date of Patent: Feb. 10, 2015. Applicant Proprietor: University of Michigan. Dr. Daniel F. Hayes is designated as inventor/co-inventor.; Diagnosis and Treatment of Breast Cancer. Patent No. US 8,790,878 B2. Date of Patent: Jul. 29, 2014. Applicant Proprietor: University of Michigan. Dr. Daniel F. Hayes is designated as inventor/co-inventor.; Royalties from licensed technology.; Title: A method for predicting progression free and overall survival at each follow-up timepoint during therapy of metastatic breast cancer patients using circulating tumor cells. Patent no. 05725638.0-1223-US2005008602.
Travel, Accommodations, Expenses - Menarini Silicon Biosystems
Other Relationship - Menarini; UpToDate
(OPTIONAL) Uncompensated Relationships - UpToDate
 
Anna Maria Storniolo
Employment - Q32 Bio (I)
Leadership - Q32 Bio (I)
Stock and Other Ownership Interests - Pfizer (I)
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Deerfield Management (I); Tri-Institutional Therapeutics Discovery Institute (I)
Research Funding - Pfizer (Inst)
 
Norah Lynn Henry
Research Funding - Blue Note Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalty from Up-to-Date